ICV Partners announced today that its portfolio company, Stauber Performance Ingredients, a manufacturer and distributor of nutritional ingredients and blends, has acquired Pharmline. “This is an important strategic step for Stauber and we are very pleased with the company’s first phase of growth over the past year. This acquisition represents the next step in building a market leading company with a national presence. Pharmline adds a range of synergistic customized services and specialized products that combined with Stauber will benefit our customers in many ways,” said Ira Moreland, a Managing Director of ICV.
Pharmline is a value-added distributor and manufacturer of nutritional ingredients with specialized processing capabilities such as mixing, drying, granulation, and micronization. It also sells and distributes
minerals, vitamins and amino acids. Pharmline also operates an in-house lab and R&D facilities where it provides testing and formulation services on behalf of its clients. The company was founded in 1986 and is based in Florida, NY (www.pharmlineinc.com).
“Pharmline is a highly respected brand that is well recognized in the nutritional industry and its value added processing capabilities, as well as their sales and technical expertise, provide a strong platform for us to pursue new market opportunities on a national scale,” said Dan Stauber, CEO of Stauber.
Stauber provides ingredients to the food, pharmaceutical, cosmetic and health food supplement industries. Products include amino acids; bioflavonoids; excipients; vitamins; botanicals; fruits and vegetables; minerals; and other specialty products. The company was founded in 1969 and is headquartered in Fullerton, CA (www.stauberusa.com).
ICV Partners invests in family-owned and closely-held businesses as well as corporate divestitures with revenues from $25 million to $250 million and EBITDAs from $5 million to $30 million. The firm has $440 million in capital under management and has offices in New York, NY and Atlanta, GA (www.icvcapital.com).
